BioHykon Overview
- Year Founded
-
2014
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Investors
-
2
BioHykon General Information
Description
Developer of diagnostic reagents and supporting equipment designed for circulating tumor cell (CTC) detection. The company develops CTC detection kit and other diagnostic equipment, committing to improving the detection and treatment of cancer.
Contact Information
Website
www.biohykon.comCorporate Office
- Room 405, Building 2
- Lane 898, Halei Road, Pudong New Area
- Shanghai
- China
Corporate Office
- Room 405, Building 2
- Lane 898, Halei Road, Pudong New Area
- Shanghai
- China
BioHykon Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 24-Jul-2018 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 18-Jun-2015 | Completed | Generating Revenue |
BioHykon Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Guodu Venture Capital | PE/Buyout | Minority | ||
| DaAn Gene | Corporation | Minority |
BioHykon FAQs
-
When was BioHykon founded?
BioHykon was founded in 2014.
-
Where is BioHykon headquartered?
BioHykon is headquartered in Shanghai, China.
-
What industry is BioHykon in?
BioHykon’s primary industry is Diagnostic Equipment.
-
Is BioHykon a private or public company?
BioHykon is a Private company.
-
What is BioHykon’s current revenue?
The current revenue for BioHykon is .
-
Who are BioHykon’s investors?
Guodu Venture Capital and DaAn Gene have invested in BioHykon.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process